Anti-CMA1/ CYM/ CYH functional antibody

Anti-CMA1/ CYM/ CYH functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CYM/CMA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T05114-Ab-1/ GM-Tg-hg-T05114-Ab-2Anti-Human CYM/CMA1 monoclonal antibodyHuman
GM-Tg-rg-T05114-Ab-1/ GM-Tg-rg-T05114-Ab-2Anti-Rat CYM/CMA1 monoclonal antibodyRat
GM-Tg-mg-T05114-Ab-1/ GM-Tg-mg-T05114-Ab-2Anti-Mouse CYM/CMA1 monoclonal antibodyMouse
GM-Tg-cynog-T05114-Ab-1/ GM-Tg-cynog-T05114-Ab-2Anti-Cynomolgus/ Rhesus macaque CYM/CMA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T05114-Ab-1/ GM-Tg-felg-T05114-Ab-2Anti-Feline CYM/CMA1 monoclonal antibodyFeline
GM-Tg-cang-T05114-Ab-1/ GM-Tg-cang-T05114-Ab-2Anti-Canine CYM/CMA1 monoclonal antibodyCanine
GM-Tg-bovg-T05114-Ab-1/ GM-Tg-bovg-T05114-Ab-2Anti-Bovine CYM/CMA1 monoclonal antibodyBovine
GM-Tg-equg-T05114-Ab-1/ GM-Tg-equg-T05114-Ab-2Anti-Equine CYM/CMA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T05114-Ab-1/ GM-Tg-hg-T05114-Ab-2; GM-Tg-rg-T05114-Ab-1/ GM-Tg-rg-T05114-Ab-2;
GM-Tg-mg-T05114-Ab-1/ GM-Tg-mg-T05114-Ab-2; GM-Tg-cynog-T05114-Ab-1/ GM-Tg-cynog-T05114-Ab-2;
GM-Tg-felg-T05114-Ab-1/ GM-Tg-felg-T05114-Ab-2; GM-Tg-cang-T05114-Ab-1/ GM-Tg-cang-T05114-Ab-2;
GM-Tg-bovg-T05114-Ab-1/ GM-Tg-bovg-T05114-Ab-2; GM-Tg-equg-T05114-Ab-1/ GM-Tg-equg-T05114-Ab-2
Products NameAnti-CYM/CMA1 monoclonal antibody
Formatmab
Target NameCYM
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CYM benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T05114-Ag-1Recombinant multi-species CMA1/ CYM/ CYH protein
    ORF Viral VectorpGMLP003483human CMA1 Lentivirus plasmid
    ORF Viral VectorvGMLP003483human CMA1 Lentivirus particle
    ORF Viral VectorpGMLPm001242mouse Cma1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001242mouse Cma1 Lentivirus particle


    Target information

    Target IDGM-T05114
    Target NameCYM
    Gene ID1215,17228,716395,490628,101084796
    Gene Symbol and Synonymschymase,CMA1,CYH,Mcp-5,Mcp5,Mcpt5,MCT1,MMCP-5
    Uniprot AccessionP23946,P21842
    Uniprot Entry NameCMA1_HUMAN,CMA1_CANLF
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000092009
    Target ClassificationN/A

    The target: CYM, gene name: CMA1, also named as CYH, MCT1, chymase. This gene encodes a chymotryptic serine proteinase that belongs to the peptidase family S1. It is expressed in mast cells and is thought to function in the degradation of the extracellular matrix, the regulation of submucosal gland secretion, and the generation of vasoactive peptides. In the heart and blood vessels, this protein, rather than angiotensin converting enzyme, is largely responsible for converting angiotensin I to the vasoactive peptide angiotensin II. Alternative splicing results in multiple variants. [provided by RefSeq, Apr 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.